Rick Wise
Stock Analyst at Stifel
(4.42)
# 249
Out of 4,829 analysts
237
Total ratings
63.73%
Success rate
11.08%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $95.21 | +20.79% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $167.22 | +33.96% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $57.08 | -3.64% | 11 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $133.24 | +8.83% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $22.68 | +23.48% | 1 | Mar 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $32 | $22.04 | +45.19% | 6 | Mar 5, 2025 | |
| LIVN LivaNova | Maintains: Buy | $72 → $60 | $44.06 | +36.18% | 6 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $33 → $30 | $28.91 | +3.77% | 6 | Feb 25, 2025 | |
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $31.00 | +54.84% | 13 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $115 → $120 | $102.86 | +16.66% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 → $90 | $73.68 | +22.15% | 23 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $380.92 | +15.51% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $154.22 | +0.51% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $536.51 | +13.70% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $156.57 | +21.35% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $30.90 | +22.98% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $6.82 | +17.30% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $3.37 | +374.78% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $70.23 | +16.76% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $69.87 | +45.99% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $83.48 | +4.22% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $4.63 | +159.18% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $80.26 | -6.55% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $22.98 | +4.44% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $15.08 | +496.82% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $12.65 | +97.63% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $51.21 | +118.71% | 5 | Oct 2, 2020 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $95.21
Upside: +20.79%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $167.22
Upside: +33.96%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $57.08
Upside: -3.64%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $133.24
Upside: +8.83%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $22.68
Upside: +23.48%
OrthoPediatrics
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $22.04
Upside: +45.19%
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $44.06
Upside: +36.18%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $28.91
Upside: +3.77%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $31.00
Upside: +54.84%
Boston Scientific
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $102.86
Upside: +16.66%
Jan 30, 2025
Upgrades: Buy
Price Target: $75 → $90
Current: $73.68
Upside: +22.15%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $380.92
Upside: +15.51%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $154.22
Upside: +0.51%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $536.51
Upside: +13.70%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $156.57
Upside: +21.35%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $30.90
Upside: +22.98%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $6.82
Upside: +17.30%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $3.37
Upside: +374.78%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $70.23
Upside: +16.76%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $69.87
Upside: +45.99%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $83.48
Upside: +4.22%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $4.63
Upside: +159.18%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $80.26
Upside: -6.55%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $22.98
Upside: +4.44%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $15.08
Upside: +496.82%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $12.65
Upside: +97.63%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $51.21
Upside: +118.71%